136 related articles for article (PubMed ID: 15950204)
1. Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis.
Schwencke C; Schmeisser A; Walter C; Wachter R; Pannach S; Weck B; Braun-Dullaeus RC; Kasper M; Strasser RH
Cardiovasc Res; 2005 Oct; 68(1):128-35. PubMed ID: 15950204
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation.
Takagi Y
Hokkaido Igaku Zasshi; 2002 May; 77(3):221-30. PubMed ID: 12056049
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells.
Yuan HY; Kuang SY; Zheng X; Ling HY; Yang YB; Yan PK; Li K; Liao DF
Acta Pharmacol Sin; 2008 May; 29(5):555-63. PubMed ID: 18430363
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1: dual role for proliferation of vascular smooth muscle cells.
Sedding DG; Braun-Dullaeus RC
Trends Cardiovasc Med; 2006 Feb; 16(2):50-5. PubMed ID: 16473762
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice.
Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y
J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954
[TBL] [Abstract][Full Text] [Related]
6. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
[TBL] [Abstract][Full Text] [Related]
7. Aging increases p16 INK4a expression in vascular smooth-muscle cells.
Rodriguez-Menocal L; Pham SM; Mateu D; St-Pierre M; Wei Y; Pestana I; Aitouche A; Vazquez-Padron RI
Biosci Rep; 2009 Sep; 30(1):11-8. PubMed ID: 19196247
[TBL] [Abstract][Full Text] [Related]
8. The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells.
Peterson TE; Kleppe LS; Caplice NM; Pan S; Mueske CS; Simari RD
Biochem Biophys Res Commun; 1999 Nov; 265(3):722-7. PubMed ID: 10600487
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.
Dwivedi A; Slater SC; George SJ
Cardiovasc Res; 2009 Jan; 81(1):178-86. PubMed ID: 18852254
[TBL] [Abstract][Full Text] [Related]
10. The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1.
Kusch A; Tkachuk S; Tkachuk N; Patecki M; Park JK; Dietz R; Haller H; Dumler I
Cardiovasc Res; 2009 Jul; 83(1):115-22. PubMed ID: 19380416
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells.
Havrda MC; Johnson MJ; O'Neill CF; Liaw L
Thromb Haemost; 2006 Sep; 96(3):361-70. PubMed ID: 16953280
[TBL] [Abstract][Full Text] [Related]
12. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo.
Bond M; Wu YJ; Sala-Newby GB; Newby AC
Cardiovasc Res; 2008 Nov; 80(2):290-8. PubMed ID: 18599477
[TBL] [Abstract][Full Text] [Related]
14. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells.
Wassmann S; Wassmann K; Jung A; Velten M; Knuefermann P; Petoumenos V; Becher U; Werner C; Mueller C; Nickenig G
J Mol Cell Cardiol; 2007 Sep; 43(3):301-7. PubMed ID: 17659301
[TBL] [Abstract][Full Text] [Related]
15. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
Chen Y; Budd RC; Kelm RJ; Sobel BE; Schneider DJ
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
[TBL] [Abstract][Full Text] [Related]
17. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
Wu YJ; Bond M; Sala-Newby GB; Newby AC
Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 deficiency stimulates neointima formation during vascular injury.
Hassan GS; Jasmin JF; Schubert W; Frank PG; Lisanti MP
Biochemistry; 2004 Jul; 43(26):8312-21. PubMed ID: 15222744
[TBL] [Abstract][Full Text] [Related]
19. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
Bond M; Sala-Newby GB; Wu YJ; Newby AC
Cardiovasc Res; 2006 Jan; 69(1):198-206. PubMed ID: 16212951
[TBL] [Abstract][Full Text] [Related]
20. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse.
Ling S; Dai A; Dilley RJ; Jones M; Simpson E; Komesaroff PA; Sudhir K
Circulation; 2004 Feb; 109(4):537-43. PubMed ID: 14732746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
